Month: December 2020

A new monograph offers a far-reaching update on research and clinical management of bipolar disorders (BDs), including epidemiology, genetics, pathogenesis, psychosocial aspects, and current and investigational therapies. “I regard this as a ‘global state-of-the-union’ type of paper designed to bring the world up to speed regarding where we’re at and where we’re going in terms
0 Comments
An integral part of Swedish culture, fika reminds us to slow down and connect. But what exactly is it, and how can we bring more of it into our lives? As I write, I’m sipping on coffee and nibbling a blueberry flapjack. If I wasn’t also working, I’d be enjoying fika – translated as a
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Federal advisers on Thursday overwhelmingly recommended an emergency clearance to Moderna Inc’s COVID-19 vaccine, while noting concerns about potential allergic reactions and the challenges of continued testing of this medicine. The US Food and Drug Administration (FDA) put Moderna’s application before its
0 Comments
NEW YORK and MAINZ, GERMANY, December 14, 2020 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced additional data on neutralizing antibody and T cell responses from the Phase 1/2 trial with BNT162b2 conducted in Germany. The study results demonstrate that BNT162b2 elicits a combined adaptive humoral and cellular immune response against SARS-CoV-2 and provide insights into
0 Comments
amivantamab Treatment for Non-Small Cell Lung Cancer Janssen Submits Application to U.S. FDA Seeking Approval of Amivantamab for the Treatment of Patients with Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations RARITAN, N.J., December 3, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a Biologics License
0 Comments
FDA Approves Margenza (margetuximab-cmkb) for Patients with Pretreated Metastatic HER2-Positive Breast Cancer ROCKVILLE, MD, Dec. 16, 2020 (GLOBE NEWSWIRE) —  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Administration (FDA) has approved Margenza, in
0 Comments
Some health-care workers are hesitant to receive coronavirus vaccinations, but hospital CEOs told CNBC on Thursday they expect attitudes to shift after a larger percentage of employees are immunized. “I think shortly everybody will want to take it,” Will Ferniany, CEO of UAB Health System in Alabama, said on “Squawk on the Street.” “About 60% are
0 Comments
A Melbourne-led research consortium investigating the impact of iron treatments on maternal and newborn health in low-income countries has received two major grants from the Bill & Melinda Gates Foundation worth almost $US 9.6 million. The funding, awarded in 2020, will support major clinical trials in Malawi, South Asia, Africa and Bangladesh, investigating whether intravenous
0 Comments
“The patient is 15 minutes late. Can you still see her?” “He missed an appointment yesterday because the bus ran late, and he’s out of Suboxone. He’s getting agitated in the waiting room, and other patients are complaining. Could you see him right away?” “Therapy group has already started. Is the facilitator willing to let
0 Comments
Science should be the cornerstone for health policy, and decisions on medical care of transgender and gender-diverse (TGD) individuals should be between a patient and their doctor. That’s according to a joint policy statement from the Endocrine Society and Pediatric Endocrine Society published in the Journal of Clinical Endocrinology & Metabolism expressing concern about recent proposed legislation that would
0 Comments
A US Food and Drug Administration (FDA) advisory committee lit a long-standing fuse, recommending that evidence from the controversial TOPCAT trial can be used to support a new indication for spironolactone. The generic aldosterone blocker is already approved for the treatment of HF with reduced ejection fraction (HFrEF).  Hopes that it could be the first
0 Comments
The Algorithm Diet Review – As many very well know, body fat is one of the most difficult things to get rid of, especially when it accumulates in areas such as the gut, thighs, buttocks, and legs. Rather than continue struggling to get rid of the excess weight, individuals may want to try a new
0 Comments
The Blood Pressure Program Review – The Blood Pressure Program is an online guide that teaches you three simple exercises that can lower your blood pressure to under 120/80 in as little as one day. There’s no need to take expensive medications that have a long list of even-worse side effects or to do exhaustive
0 Comments
We’ve all been there. Whether it’s a coworker telling you that you shouldn’t join in on the company cake or a friend who makes an ignorant joke, there are many times where we are put into social situations where diabetes is a brunt of a joke or just blatantly misunderstood. How does this make a
0 Comments
Treatment for Eosinophilic Esophagitis U.S. Food and Drug Administration Accepts New Drug Application for Review, Grants Priority Review for Takeda’s TAK-721 (budesonide oral suspension) for the Treatment of Eosinophilic Esophagitis Osaka, JAPAN, December 15, 2020 – Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted
0 Comments
FDA Approves Klisyri (tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp BUFFALO, N.Y., Dec. 15, 2020 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that the U.S. Food
0 Comments
Former Trump campaign aide Michael Caputo arrives to testify before the House Intelligence Committee during a closed-door session at the U.S. Capitol Visitors Center July 14, 2017 in Washington, DC. Getty Images Top Trump appointees at the Department of Health and Human Services repeatedly pushed this summer to adopt a Covid-19 strategy in the U.S.
0 Comments
A new paper released by Columbia University Mailman School of Public Health reports a strong association between a high number of adverse childhood experiences (ACEs) and contact with the U.S. justice system. Analyzing data from eleven studies, the researchers found that results were consistent across multiple types of justice system contact and across diverse geographic
0 Comments
In a few days, winter begins.How do you feel about that? Many see it as a season to endure … too dark, too cold, too bleak. Spring and its burst of warmth, life, and activity cannot come early enough. What if, this year, you do more than simply endure winter? What if you fully embrace
0 Comments
WASHINGTON — “Expect the unexpected” applies to many things — including distribution of the Pfizer/BioNTech COVID-19 vaccine. At a press briefing Wednesday, Gen. Gustave Perna, chief operating officer of Operation Warp Speed, the Trump administration’s effort to speed up development of COVID-19 vaccines and therapeutics, said that two trays of vaccines headed for delivery to
0 Comments